Zivo Bioscience, Inc.Zivo Bioscience, Inc.Zivo Bioscience, Inc.

Zivo Bioscience, Inc.

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪38.40 M‬USD
−2.2663USD
‪−13.38 M‬USD
‪157.22 K‬USD
‪1.69 M‬
Beta (1Y)
1.22

About Zivo Bioscience, Inc.


CEO
John Bernard Payne
Headquarters
Troy
Founded
1983
Identifiers
3
ISIN US98978N1191
Zivo Bioscience, Inc. engages in the study, development, and commercialization of natural nutritional compounds and bioactive molecules. It offers proprietary algae strain, extracts and supernatants, and bioactive compounds. The company was founded by Howard R. Baer on March 28, 1983 and is headquartered in Troy, MI.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Displays a symbol's price movements over previous years to identify recurring trends.